Indonesia media executive says company talking to Disney; tycoon founder denies
JAKARTA (Reuters) - The director of the investment arm of Indonesian media group Media Nusantara Citra (MNC) said on Tuesday the group was in talks with Walt Disney Co on a possible investment by the U.S. media conglomerate, but the group's owner Hary Tanoesoedibjo denied talks were taking place. MNC Investama Director Darma Putra said at an event organized by MNC that Disney was interested in investing in one of the group's affiliates
JAKARTA (Reuters) - The director of the investment arm of Indonesian media group Media Nusantara Citra (MNC) said on Tuesday the group was in talks with Walt Disney Co on a possible investment by the U.S. media conglomerate, but the group's owner Hary Tanoesoedibjo denied talks were taking place.
MNC Investama Director Darma Putra said at an event organized by MNC that Disney was interested in investing in one of the group's affiliates.
“Hopefully, we will get another (equity investor) soon. We are in talks with Disney. If it’s successful, it will earn $200 million in the next 10 years,” Putra told an audience that included reporters.
MNC Group founder and chairman Hary Tanoesoedibjo, a business partner of U.S. president Donald Trump, said no talks were taking place with Disney. MNC Group said last year it was building two luxury resorts in Indonesia that will be managed by a subsidiary of the Trump Organization.He told Reuters by telephone there were "clearly no talks with Disney", adding he would know since he was the “number one guy at MNC”.
Tanoesoedibjo said that negotiations with Vivendi were ongoing and the French company as now looking to buy a stake through its subsidiary Canal Plus in MNC Vision Networks (MVN), an affiliate of MNC.
Tanoesoedibjo also said MVN was planning a public listing to attract investors.
The Indonesian tycoon is known for his flamboyant business style and has previously said he was inspired by Trump.
Disney and Vivendi did not immediately respond to requests for comment.
(Reporting by Cindy Silviana; Editing by Edmund Blair/Emelia Sithole-Matarise/Jane Merriman)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.